RecruitingPhase 4NCT07092527

Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version


Sponsor

University of California, San Diego

Enrollment

80 participants

Start Date

Dec 5, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This research study investigates whether male-level exogenous androgens inhibit the reproductive neuroendocrine axis in otherwise healthy (non-PCOS) females.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 35 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Testosterone Cypionate 50 milligrams per millileter (mg/mL) Injectable Solution for people with reproductive issues and transgenderism. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 35 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTestosterone Cypionate 50 milligrams per millileter (mg/mL) Injectable Solution

Participants in the initiating group will receive weekly doses of testosterone for gender-affirming care.


Locations(1)

University of California, San Diego

San Diego, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07092527


Related Trials